Motif ID: Nr1i3
Z-value: 1.161
Transcription factors associated with Nr1i3:
| Gene Symbol | Entrez ID | Gene Name |
|---|---|---|
| Nr1i3 | ENSMUSG00000005677.8 | Nr1i3 |
Activity-expression correlation:
| Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| Nr1i3 | mm10_v2_chr1_+_171213969_171214007 | 0.12 | 2.9e-01 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.0 | 14.8 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
| 2.4 | 9.8 | GO:0015889 | cobalamin transport(GO:0015889) |
| 2.2 | 6.6 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 1.4 | 12.9 | GO:0071493 | cellular response to UV-B(GO:0071493) |
| 1.4 | 4.1 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
| 1.2 | 3.7 | GO:0072554 | arterial endothelial cell fate commitment(GO:0060844) blood vessel endothelial cell fate commitment(GO:0060846) endothelial cell fate specification(GO:0060847) Notch signaling pathway involved in arterial endothelial cell fate commitment(GO:0060853) blood vessel lumenization(GO:0072554) blood vessel endothelial cell fate specification(GO:0097101) |
| 1.1 | 5.6 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 1.1 | 4.3 | GO:0046210 | nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
| 1.1 | 4.3 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
| 1.0 | 3.1 | GO:0046544 | regulation of natural killer cell proliferation(GO:0032817) positive regulation of natural killer cell proliferation(GO:0032819) development of secondary male sexual characteristics(GO:0046544) |
| 1.0 | 3.1 | GO:0036388 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) DNA replication preinitiation complex assembly(GO:0071163) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 1.0 | 7.1 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
| 1.0 | 10.5 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
| 0.9 | 2.8 | GO:0031660 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) |
| 0.9 | 2.7 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
| 0.9 | 5.2 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
| 0.9 | 2.6 | GO:0036166 | phenotypic switching(GO:0036166) |
| 0.8 | 5.1 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
| 0.8 | 7.5 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.8 | 3.3 | GO:0002481 | antigen processing and presentation of exogenous peptide antigen via MHC class Ib(GO:0002477) antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent(GO:0002481) |
| 0.8 | 3.9 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.8 | 3.9 | GO:0052428 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.8 | 13.0 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.8 | 3.0 | GO:0040038 | polar body extrusion after meiotic divisions(GO:0040038) |
| 0.7 | 4.5 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 0.7 | 1.4 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.7 | 5.3 | GO:0006004 | fucose metabolic process(GO:0006004) |
| 0.6 | 1.9 | GO:0010040 | response to iron(II) ion(GO:0010040) |
| 0.6 | 0.6 | GO:1904959 | regulation of electron carrier activity(GO:1904732) regulation of cytochrome-c oxidase activity(GO:1904959) |
| 0.6 | 6.9 | GO:0030432 | peristalsis(GO:0030432) |
| 0.6 | 1.9 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 0.6 | 2.4 | GO:0036482 | neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036482) positive regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902958) regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903383) negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903384) |
| 0.6 | 2.4 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
| 0.6 | 1.8 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
| 0.6 | 1.8 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
| 0.6 | 1.7 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
| 0.6 | 2.2 | GO:0035470 | positive regulation of vascular wound healing(GO:0035470) |
| 0.6 | 3.9 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
| 0.6 | 1.7 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 0.6 | 1.7 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) cysteine biosynthetic process(GO:0019344) |
| 0.6 | 0.6 | GO:0010813 | neuropeptide catabolic process(GO:0010813) |
| 0.5 | 1.6 | GO:0006553 | lysine metabolic process(GO:0006553) |
| 0.5 | 1.6 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
| 0.5 | 4.9 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
| 0.5 | 3.2 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.5 | 0.5 | GO:1903760 | regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903760) regulation of membrane repolarization during ventricular cardiac muscle cell action potential(GO:1905024) |
| 0.5 | 1.1 | GO:0060166 | olfactory pit development(GO:0060166) |
| 0.5 | 1.6 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.5 | 3.7 | GO:0000279 | M phase(GO:0000279) |
| 0.5 | 2.6 | GO:0046864 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) alveolar primary septum development(GO:0061143) |
| 0.5 | 1.6 | GO:0061642 | chemoattraction of axon(GO:0061642) |
| 0.5 | 2.1 | GO:0051541 | elastin metabolic process(GO:0051541) |
| 0.5 | 2.6 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
| 0.5 | 2.0 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.5 | 1.5 | GO:0090289 | regulation of osteoclast proliferation(GO:0090289) |
| 0.5 | 1.5 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.5 | 0.5 | GO:0032042 | mitochondrial DNA metabolic process(GO:0032042) |
| 0.5 | 1.5 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
| 0.5 | 1.5 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
| 0.5 | 1.5 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
| 0.5 | 0.5 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
| 0.5 | 1.9 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.5 | 1.9 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
| 0.5 | 1.4 | GO:0014877 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.5 | 2.3 | GO:1904721 | regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) negative regulation of immunoglobulin secretion(GO:0051025) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
| 0.5 | 0.5 | GO:0002428 | antigen processing and presentation of peptide antigen via MHC class Ib(GO:0002428) |
| 0.5 | 2.8 | GO:0021539 | subthalamus development(GO:0021539) |
| 0.5 | 2.8 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
| 0.5 | 1.4 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
| 0.5 | 1.4 | GO:0036292 | DNA rewinding(GO:0036292) |
| 0.5 | 2.3 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
| 0.4 | 1.3 | GO:0035696 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
| 0.4 | 1.8 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
| 0.4 | 1.3 | GO:1904578 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
| 0.4 | 3.1 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.4 | 1.3 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.4 | 1.7 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
| 0.4 | 2.6 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 0.4 | 1.3 | GO:0042560 | 10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 0.4 | 3.4 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
| 0.4 | 2.1 | GO:0042256 | mature ribosome assembly(GO:0042256) |
| 0.4 | 1.7 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
| 0.4 | 3.7 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
| 0.4 | 2.5 | GO:0001980 | regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
| 0.4 | 1.2 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
| 0.4 | 2.4 | GO:0030913 | paranodal junction assembly(GO:0030913) |
| 0.4 | 1.2 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.4 | 1.6 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
| 0.4 | 1.6 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 0.4 | 1.5 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
| 0.4 | 1.5 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.4 | 3.8 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.4 | 3.4 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.4 | 5.0 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
| 0.4 | 2.7 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.4 | 1.5 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
| 0.4 | 1.5 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 0.4 | 2.6 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
| 0.4 | 0.7 | GO:0006083 | acetate metabolic process(GO:0006083) |
| 0.4 | 1.8 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
| 0.4 | 11.7 | GO:0042775 | mitochondrial ATP synthesis coupled electron transport(GO:0042775) |
| 0.4 | 0.7 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
| 0.4 | 1.4 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.4 | 5.3 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
| 0.4 | 0.4 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
| 0.4 | 7.5 | GO:0038092 | nodal signaling pathway(GO:0038092) |
| 0.4 | 3.2 | GO:0048102 | autophagic cell death(GO:0048102) |
| 0.4 | 7.0 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 0.4 | 0.7 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
| 0.3 | 1.0 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
| 0.3 | 2.4 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
| 0.3 | 3.5 | GO:0048617 | embryonic foregut morphogenesis(GO:0048617) |
| 0.3 | 12.4 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.3 | 3.4 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
| 0.3 | 1.0 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.3 | 1.0 | GO:0010896 | regulation of triglyceride catabolic process(GO:0010896) positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.3 | 1.7 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
| 0.3 | 2.0 | GO:0007144 | female meiosis I(GO:0007144) |
| 0.3 | 1.0 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.3 | 0.7 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
| 0.3 | 1.3 | GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development(GO:0072272) |
| 0.3 | 2.6 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
| 0.3 | 1.0 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.3 | 1.9 | GO:0060539 | diaphragm development(GO:0060539) |
| 0.3 | 1.9 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.3 | 5.5 | GO:0051451 | myoblast migration(GO:0051451) |
| 0.3 | 1.0 | GO:0070476 | rRNA (guanine-N7)-methylation(GO:0070476) |
| 0.3 | 2.2 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
| 0.3 | 2.2 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.3 | 1.3 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
| 0.3 | 0.9 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.3 | 0.6 | GO:0006507 | GPI anchor release(GO:0006507) |
| 0.3 | 3.7 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
| 0.3 | 1.6 | GO:1903232 | melanosome assembly(GO:1903232) |
| 0.3 | 1.6 | GO:1900170 | negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
| 0.3 | 5.3 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.3 | 2.2 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
| 0.3 | 0.6 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
| 0.3 | 0.6 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 0.3 | 3.4 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
| 0.3 | 1.2 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) notochord regression(GO:0060032) |
| 0.3 | 3.0 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.3 | 1.2 | GO:0030091 | protein repair(GO:0030091) |
| 0.3 | 2.7 | GO:0048664 | neuron fate determination(GO:0048664) |
| 0.3 | 2.7 | GO:1900194 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
| 0.3 | 0.9 | GO:0046370 | fructose biosynthetic process(GO:0046370) |
| 0.3 | 2.4 | GO:0021546 | rhombomere development(GO:0021546) |
| 0.3 | 2.4 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
| 0.3 | 2.3 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
| 0.3 | 2.0 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.3 | 2.0 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
| 0.3 | 1.2 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.3 | 1.2 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.3 | 0.6 | GO:0035973 | aggrephagy(GO:0035973) |
| 0.3 | 1.7 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
| 0.3 | 2.9 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
| 0.3 | 0.9 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.3 | 1.1 | GO:0043973 | histone H3-K4 acetylation(GO:0043973) |
| 0.3 | 3.4 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 0.3 | 3.7 | GO:0006517 | protein deglycosylation(GO:0006517) |
| 0.3 | 0.8 | GO:0021972 | corticospinal neuron axon guidance through spinal cord(GO:0021972) positive regulation of negative chemotaxis(GO:0050924) induction of negative chemotaxis(GO:0050929) negative regulation of mononuclear cell migration(GO:0071676) negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
| 0.3 | 0.8 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.3 | 1.9 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
| 0.3 | 1.1 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
| 0.3 | 2.2 | GO:0048625 | myoblast fate commitment(GO:0048625) |
| 0.3 | 0.8 | GO:0021933 | radial glia guided migration of cerebellar granule cell(GO:0021933) |
| 0.3 | 1.9 | GO:0015862 | uridine transport(GO:0015862) |
| 0.3 | 1.6 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.3 | 1.6 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
| 0.3 | 3.2 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
| 0.3 | 1.1 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.3 | 3.7 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
| 0.3 | 1.3 | GO:0016139 | glycoside catabolic process(GO:0016139) |
| 0.3 | 1.0 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.3 | 1.3 | GO:0015671 | oxygen transport(GO:0015671) |
| 0.3 | 0.5 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
| 0.3 | 0.5 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
| 0.3 | 1.0 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.3 | 1.3 | GO:0070166 | enamel mineralization(GO:0070166) |
| 0.3 | 0.3 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
| 0.3 | 2.5 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.3 | 1.0 | GO:0035552 | oxidative single-stranded DNA demethylation(GO:0035552) oxidative single-stranded RNA demethylation(GO:0035553) |
| 0.3 | 0.8 | GO:1903002 | lipoprotein catabolic process(GO:0042159) regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) regulation of lipid transport across blood brain barrier(GO:1903000) positive regulation of lipid transport across blood brain barrier(GO:1903002) |
| 0.2 | 1.7 | GO:0035754 | B cell chemotaxis(GO:0035754) |
| 0.2 | 1.0 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.2 | 1.7 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
| 0.2 | 2.7 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.2 | 2.0 | GO:0006105 | succinate metabolic process(GO:0006105) |
| 0.2 | 1.2 | GO:2000987 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
| 0.2 | 0.5 | GO:0051715 | cytolysis in other organism(GO:0051715) |
| 0.2 | 0.7 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
| 0.2 | 1.0 | GO:1900150 | regulation of defense response to fungus(GO:1900150) |
| 0.2 | 0.7 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
| 0.2 | 1.2 | GO:1904426 | positive regulation of GTP binding(GO:1904426) |
| 0.2 | 0.5 | GO:0086028 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
| 0.2 | 1.0 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
| 0.2 | 0.7 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
| 0.2 | 0.9 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
| 0.2 | 2.8 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
| 0.2 | 0.5 | GO:0060056 | mammary gland involution(GO:0060056) |
| 0.2 | 1.4 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
| 0.2 | 2.8 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.2 | 0.9 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 0.2 | 0.9 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.2 | 0.9 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
| 0.2 | 0.2 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.2 | 0.7 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.2 | 0.2 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.2 | 2.8 | GO:0048368 | lateral mesoderm development(GO:0048368) |
| 0.2 | 0.9 | GO:0015744 | succinate transport(GO:0015744) |
| 0.2 | 1.1 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.2 | 0.7 | GO:0042637 | catagen(GO:0042637) |
| 0.2 | 1.6 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.2 | 1.4 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.2 | 3.6 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
| 0.2 | 0.4 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
| 0.2 | 0.7 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.2 | 0.9 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.2 | 0.7 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
| 0.2 | 0.7 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
| 0.2 | 1.3 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.2 | 0.4 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
| 0.2 | 0.6 | GO:0006116 | NADH oxidation(GO:0006116) |
| 0.2 | 1.1 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
| 0.2 | 0.4 | GO:0033864 | positive regulation of NAD(P)H oxidase activity(GO:0033864) flavin-containing compound metabolic process(GO:0042726) |
| 0.2 | 0.9 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
| 0.2 | 0.6 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
| 0.2 | 0.6 | GO:0031424 | keratinization(GO:0031424) |
| 0.2 | 4.5 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
| 0.2 | 0.6 | GO:0070375 | ERK5 cascade(GO:0070375) |
| 0.2 | 0.4 | GO:0010958 | regulation of amino acid import(GO:0010958) |
| 0.2 | 0.6 | GO:0031161 | phosphatidylinositol catabolic process(GO:0031161) |
| 0.2 | 0.6 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
| 0.2 | 2.1 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
| 0.2 | 1.0 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
| 0.2 | 0.8 | GO:0003161 | cardiac conduction system development(GO:0003161) |
| 0.2 | 1.0 | GO:1904672 | regulation of somatic stem cell population maintenance(GO:1904672) |
| 0.2 | 2.2 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
| 0.2 | 0.8 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 0.2 | 1.2 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.2 | 0.6 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
| 0.2 | 1.8 | GO:0031017 | exocrine pancreas development(GO:0031017) positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.2 | 0.6 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
| 0.2 | 2.0 | GO:0019430 | removal of superoxide radicals(GO:0019430) |
| 0.2 | 1.4 | GO:0009249 | protein lipoylation(GO:0009249) |
| 0.2 | 1.4 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
| 0.2 | 0.8 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.2 | 0.6 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
| 0.2 | 5.4 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.2 | 0.2 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 0.2 | 0.8 | GO:0051933 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
| 0.2 | 0.8 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.2 | 0.4 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
| 0.2 | 1.7 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.2 | 0.4 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
| 0.2 | 0.2 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
| 0.2 | 0.8 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
| 0.2 | 5.8 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
| 0.2 | 0.6 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.2 | 0.7 | GO:0030202 | heparin metabolic process(GO:0030202) |
| 0.2 | 0.7 | GO:1902340 | telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
| 0.2 | 0.7 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
| 0.2 | 1.1 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
| 0.2 | 0.2 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
| 0.2 | 1.6 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 0.2 | 1.5 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.2 | 1.8 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
| 0.2 | 0.9 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
| 0.2 | 0.2 | GO:1902256 | apoptotic process involved in outflow tract morphogenesis(GO:0003275) apoptotic process involved in heart morphogenesis(GO:0003278) regulation of apoptotic process involved in outflow tract morphogenesis(GO:1902256) response to chemokine(GO:1990868) cellular response to chemokine(GO:1990869) |
| 0.2 | 1.1 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
| 0.2 | 1.3 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.2 | 1.1 | GO:1903273 | regulation of sodium ion export(GO:1903273) positive regulation of sodium ion export(GO:1903275) regulation of sodium ion export from cell(GO:1903276) positive regulation of sodium ion export from cell(GO:1903278) |
| 0.2 | 1.6 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
| 0.2 | 1.6 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.2 | 0.4 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
| 0.2 | 0.7 | GO:0060768 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 0.2 | 3.9 | GO:2001273 | regulation of glucose import in response to insulin stimulus(GO:2001273) |
| 0.2 | 0.7 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.2 | 1.9 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
| 0.2 | 0.5 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
| 0.2 | 10.5 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
| 0.2 | 2.8 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
| 0.2 | 1.9 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
| 0.2 | 3.6 | GO:0046596 | regulation of viral entry into host cell(GO:0046596) |
| 0.2 | 1.7 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
| 0.2 | 0.7 | GO:0061188 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.2 | 0.7 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
| 0.2 | 4.4 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
| 0.2 | 1.2 | GO:0070986 | left/right axis specification(GO:0070986) |
| 0.2 | 1.7 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
| 0.2 | 0.7 | GO:0090168 | Golgi reassembly(GO:0090168) |
| 0.2 | 0.3 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
| 0.2 | 0.3 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) lobar bronchus development(GO:0060482) |
| 0.2 | 1.3 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
| 0.2 | 0.3 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.2 | 1.0 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.2 | 0.7 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
| 0.2 | 0.6 | GO:0015786 | UDP-glucose transport(GO:0015786) protein O-linked fucosylation(GO:0036066) |
| 0.2 | 1.0 | GO:0015074 | DNA integration(GO:0015074) |
| 0.2 | 1.1 | GO:0060307 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) |
| 0.2 | 1.1 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
| 0.2 | 3.7 | GO:0006783 | heme biosynthetic process(GO:0006783) |
| 0.2 | 5.0 | GO:0035411 | catenin import into nucleus(GO:0035411) |
| 0.2 | 0.2 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
| 0.2 | 2.5 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
| 0.2 | 1.6 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.2 | 0.8 | GO:0046512 | sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
| 0.2 | 0.6 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 0.2 | 0.8 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.2 | 0.8 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
| 0.2 | 0.6 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.2 | 0.8 | GO:0015817 | glutamine transport(GO:0006868) histidine transport(GO:0015817) cellular response to potassium ion starvation(GO:0051365) |
| 0.2 | 0.5 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
| 0.2 | 0.6 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.2 | 1.1 | GO:0015675 | nickel cation transport(GO:0015675) |
| 0.2 | 0.5 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.2 | 2.4 | GO:0006337 | nucleosome disassembly(GO:0006337) |
| 0.2 | 1.4 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.2 | 0.5 | GO:0008050 | female courtship behavior(GO:0008050) |
| 0.2 | 0.9 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
| 0.1 | 0.9 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.1 | 0.3 | GO:0043366 | beta selection(GO:0043366) |
| 0.1 | 0.7 | GO:0002667 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) negative regulation of protein kinase C signaling(GO:0090038) |
| 0.1 | 0.9 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 0.1 | 0.6 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.1 | 0.9 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
| 0.1 | 0.7 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
| 0.1 | 0.9 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
| 0.1 | 0.9 | GO:0032196 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) transposition(GO:0032196) |
| 0.1 | 0.7 | GO:0060430 | lung saccule development(GO:0060430) |
| 0.1 | 0.3 | GO:0010920 | negative regulation of inositol phosphate biosynthetic process(GO:0010920) |
| 0.1 | 0.3 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 0.1 | 1.1 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.1 | 2.4 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.1 | 0.1 | GO:0014062 | regulation of serotonin secretion(GO:0014062) |
| 0.1 | 0.6 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) positive regulation of translational initiation by iron(GO:0045994) secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.1 | 0.3 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
| 0.1 | 0.5 | GO:0052695 | cellular glucuronidation(GO:0052695) |
| 0.1 | 0.3 | GO:0001978 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) |
| 0.1 | 1.6 | GO:0008272 | sulfate transport(GO:0008272) |
| 0.1 | 0.4 | GO:0071544 | diphosphoinositol polyphosphate catabolic process(GO:0071544) |
| 0.1 | 1.5 | GO:0010883 | regulation of lipid storage(GO:0010883) |
| 0.1 | 0.4 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.1 | 0.5 | GO:0035902 | response to immobilization stress(GO:0035902) |
| 0.1 | 0.3 | GO:0072014 | proximal tubule development(GO:0072014) |
| 0.1 | 0.1 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.1 | 1.5 | GO:0006817 | phosphate ion transport(GO:0006817) |
| 0.1 | 1.3 | GO:0003417 | growth plate cartilage development(GO:0003417) |
| 0.1 | 0.7 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
| 0.1 | 0.4 | GO:0001193 | maintenance of transcriptional fidelity during DNA-templated transcription elongation(GO:0001192) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter(GO:0001193) |
| 0.1 | 0.5 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
| 0.1 | 0.4 | GO:0032474 | otolith morphogenesis(GO:0032474) |
| 0.1 | 0.4 | GO:0060745 | mammary gland branching involved in pregnancy(GO:0060745) |
| 0.1 | 0.8 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.1 | 0.5 | GO:0010155 | regulation of proton transport(GO:0010155) |
| 0.1 | 3.6 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
| 0.1 | 0.8 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.1 | 1.0 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.1 | 0.8 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
| 0.1 | 0.4 | GO:1901421 | generation of catalytic spliceosome for second transesterification step(GO:0000350) positive regulation of response to alcohol(GO:1901421) |
| 0.1 | 0.8 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
| 0.1 | 0.8 | GO:0044364 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
| 0.1 | 1.9 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
| 0.1 | 0.8 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
| 0.1 | 1.3 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.1 | 3.8 | GO:0009409 | response to cold(GO:0009409) |
| 0.1 | 0.1 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
| 0.1 | 3.9 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.1 | 0.4 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
| 0.1 | 1.1 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
| 0.1 | 0.6 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
| 0.1 | 1.8 | GO:0006801 | superoxide metabolic process(GO:0006801) |
| 0.1 | 1.3 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
| 0.1 | 0.4 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
| 0.1 | 0.4 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
| 0.1 | 1.4 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.1 | 1.2 | GO:0045792 | negative regulation of cell size(GO:0045792) |
| 0.1 | 1.3 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
| 0.1 | 0.6 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.1 | 3.4 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
| 0.1 | 0.7 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.1 | 1.3 | GO:0009404 | toxin metabolic process(GO:0009404) |
| 0.1 | 0.8 | GO:0015824 | proline transport(GO:0015824) |
| 0.1 | 0.2 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
| 0.1 | 2.1 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
| 0.1 | 2.1 | GO:0019835 | cytolysis(GO:0019835) |
| 0.1 | 1.5 | GO:0055012 | ventricular cardiac muscle cell differentiation(GO:0055012) |
| 0.1 | 0.2 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
| 0.1 | 0.9 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
| 0.1 | 0.4 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
| 0.1 | 0.3 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 0.1 | 3.7 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
| 0.1 | 0.8 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
| 0.1 | 0.6 | GO:0023021 | termination of signal transduction(GO:0023021) termination of G-protein coupled receptor signaling pathway(GO:0038032) |
| 0.1 | 0.2 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 0.1 | 1.5 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
| 0.1 | 1.1 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
| 0.1 | 3.5 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 0.1 | 1.5 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.1 | 0.4 | GO:0099527 | postsynapse to nucleus signaling pathway(GO:0099527) |
| 0.1 | 0.8 | GO:0070475 | rRNA base methylation(GO:0070475) |
| 0.1 | 0.8 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.1 | 0.8 | GO:0050000 | chromosome localization(GO:0050000) establishment of chromosome localization(GO:0051303) |
| 0.1 | 1.3 | GO:1903020 | positive regulation of glycoprotein metabolic process(GO:1903020) |
| 0.1 | 0.6 | GO:0043144 | snoRNA processing(GO:0043144) |
| 0.1 | 0.5 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.1 | 0.4 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
| 0.1 | 3.1 | GO:0006749 | glutathione metabolic process(GO:0006749) |
| 0.1 | 0.6 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
| 0.1 | 0.5 | GO:0044241 | lipid digestion(GO:0044241) |
| 0.1 | 0.3 | GO:0031038 | myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
| 0.1 | 2.1 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.1 | 0.5 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
| 0.1 | 0.6 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
| 0.1 | 1.3 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
| 0.1 | 0.5 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
| 0.1 | 0.8 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.1 | 2.5 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
| 0.1 | 0.2 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
| 0.1 | 0.6 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
| 0.1 | 0.5 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.1 | 0.9 | GO:0051353 | positive regulation of oxidoreductase activity(GO:0051353) |
| 0.1 | 0.5 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
| 0.1 | 0.6 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
| 0.1 | 0.9 | GO:1902176 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902176) |
| 0.1 | 0.1 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.1 | 0.4 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.1 | 0.4 | GO:0010755 | regulation of plasminogen activation(GO:0010755) |
| 0.1 | 0.5 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
| 0.1 | 0.2 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.1 | 0.5 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
| 0.1 | 0.2 | GO:0061724 | lipophagy(GO:0061724) |
| 0.1 | 3.3 | GO:0032648 | regulation of interferon-beta production(GO:0032648) |
| 0.1 | 0.7 | GO:0072189 | ureter development(GO:0072189) |
| 0.1 | 0.5 | GO:0098706 | copper ion import(GO:0015677) ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
| 0.1 | 0.9 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
| 0.1 | 0.3 | GO:1990000 | amyloid fibril formation(GO:1990000) |
| 0.1 | 1.3 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
| 0.1 | 1.2 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
| 0.1 | 0.7 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.1 | 1.1 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
| 0.1 | 0.9 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
| 0.1 | 2.9 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.1 | 0.5 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
| 0.1 | 0.7 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
| 0.1 | 0.3 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.1 | 0.1 | GO:0007521 | muscle cell fate determination(GO:0007521) |
| 0.1 | 0.6 | GO:0046785 | microtubule polymerization(GO:0046785) |
| 0.1 | 1.6 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
| 0.1 | 0.3 | GO:1901355 | response to rapamycin(GO:1901355) |
| 0.1 | 0.3 | GO:2000619 | negative regulation of histone H4-K16 acetylation(GO:2000619) |
| 0.1 | 0.4 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
| 0.1 | 0.4 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 0.1 | 0.9 | GO:0050892 | intestinal absorption(GO:0050892) |
| 0.1 | 0.8 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
| 0.1 | 0.9 | GO:0006012 | galactose metabolic process(GO:0006012) |
| 0.1 | 0.5 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
| 0.1 | 0.3 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
| 0.1 | 1.2 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
| 0.1 | 0.2 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) regulation of membrane repolarization during cardiac muscle cell action potential(GO:1905031) |
| 0.1 | 0.5 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
| 0.1 | 0.3 | GO:0097494 | regulation of vesicle size(GO:0097494) |
| 0.1 | 0.8 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
| 0.1 | 0.6 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
| 0.1 | 3.0 | GO:0006818 | hydrogen transport(GO:0006818) |
| 0.1 | 1.5 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
| 0.1 | 0.6 | GO:0015868 | purine nucleotide transport(GO:0015865) purine ribonucleotide transport(GO:0015868) |
| 0.1 | 0.4 | GO:0033561 | regulation of water loss via skin(GO:0033561) establishment of skin barrier(GO:0061436) |
| 0.1 | 1.4 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
| 0.1 | 0.8 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
| 0.1 | 0.6 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.1 | 0.9 | GO:0050909 | sensory perception of taste(GO:0050909) |
| 0.1 | 0.1 | GO:2000561 | CD4-positive, alpha-beta T cell proliferation(GO:0035739) negative regulation of alpha-beta T cell proliferation(GO:0046642) regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 0.1 | 0.4 | GO:0032462 | regulation of protein homooligomerization(GO:0032462) |
| 0.1 | 0.7 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
| 0.1 | 0.8 | GO:0033687 | osteoblast proliferation(GO:0033687) |
| 0.1 | 3.5 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
| 0.1 | 0.9 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
| 0.1 | 0.5 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
| 0.1 | 0.4 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.1 | 0.3 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.1 | 0.2 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
| 0.1 | 0.6 | GO:0070236 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.1 | 1.8 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.1 | 0.5 | GO:0051608 | histamine transport(GO:0051608) |
| 0.1 | 0.1 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.1 | 0.6 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.1 | 0.3 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
| 0.1 | 1.0 | GO:0072520 | seminiferous tubule development(GO:0072520) |
| 0.1 | 0.4 | GO:0034214 | protein hexamerization(GO:0034214) |
| 0.1 | 0.4 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
| 0.1 | 0.6 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
| 0.1 | 0.1 | GO:0048840 | otolith development(GO:0048840) |
| 0.1 | 0.2 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
| 0.1 | 0.5 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
| 0.1 | 0.7 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.1 | 0.4 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
| 0.1 | 1.4 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.1 | 0.2 | GO:1990523 | bone regeneration(GO:1990523) |
| 0.1 | 0.4 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
| 0.1 | 3.7 | GO:0032543 | mitochondrial translation(GO:0032543) |
| 0.1 | 0.7 | GO:0071168 | protein localization to chromatin(GO:0071168) |
| 0.1 | 0.9 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
| 0.1 | 0.3 | GO:0071361 | cellular response to ethanol(GO:0071361) |
| 0.1 | 0.6 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
| 0.1 | 0.1 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
| 0.1 | 0.2 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
| 0.1 | 0.6 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
| 0.1 | 0.1 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
| 0.1 | 0.2 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.1 | 1.8 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.1 | 0.3 | GO:0019359 | NADP biosynthetic process(GO:0006741) nicotinamide nucleotide biosynthetic process(GO:0019359) |
| 0.1 | 0.3 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
| 0.1 | 0.1 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
| 0.1 | 0.7 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.1 | 0.7 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.1 | 0.4 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
| 0.1 | 0.3 | GO:0050812 | regulation of acyl-CoA biosynthetic process(GO:0050812) |
| 0.1 | 0.5 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.1 | 0.2 | GO:0019363 | pyridine nucleotide biosynthetic process(GO:0019363) |
| 0.1 | 0.3 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 0.1 | 0.4 | GO:0021678 | third ventricle development(GO:0021678) |
| 0.1 | 1.4 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
| 0.1 | 0.6 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
| 0.1 | 0.3 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
| 0.1 | 0.4 | GO:0006020 | inositol metabolic process(GO:0006020) |
| 0.1 | 0.5 | GO:0046855 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
| 0.1 | 2.2 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
| 0.1 | 0.2 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
| 0.1 | 0.5 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
| 0.1 | 0.8 | GO:0002076 | osteoblast development(GO:0002076) |
| 0.1 | 0.2 | GO:1901837 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 0.1 | 0.2 | GO:0018094 | protein polyglycylation(GO:0018094) |
| 0.1 | 0.2 | GO:0071594 | T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
| 0.1 | 1.2 | GO:0043153 | photoperiodism(GO:0009648) entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.1 | 1.7 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.1 | 0.2 | GO:0032753 | positive regulation of interleukin-4 production(GO:0032753) |
| 0.1 | 0.1 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
| 0.1 | 0.2 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
| 0.1 | 1.0 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.1 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
| 0.1 | 1.1 | GO:0032801 | receptor catabolic process(GO:0032801) |
| 0.1 | 1.9 | GO:0048260 | positive regulation of receptor-mediated endocytosis(GO:0048260) |
| 0.1 | 1.1 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
| 0.1 | 0.1 | GO:0035455 | response to interferon-alpha(GO:0035455) |
| 0.1 | 1.6 | GO:0070206 | protein trimerization(GO:0070206) |
| 0.1 | 0.8 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
| 0.1 | 0.3 | GO:0097646 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.1 | 0.3 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
| 0.1 | 0.4 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
| 0.1 | 0.3 | GO:0090166 | Golgi disassembly(GO:0090166) |
| 0.1 | 0.3 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.1 | 0.5 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
| 0.0 | 0.8 | GO:0034508 | centromere complex assembly(GO:0034508) |
| 0.0 | 0.4 | GO:0050832 | defense response to fungus(GO:0050832) |
| 0.0 | 0.1 | GO:2000182 | regulation of progesterone biosynthetic process(GO:2000182) |
| 0.0 | 0.2 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 0.0 | 0.6 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.0 | 0.1 | GO:0060290 | transdifferentiation(GO:0060290) |
| 0.0 | 0.3 | GO:0051341 | regulation of oxidoreductase activity(GO:0051341) |
| 0.0 | 0.9 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
| 0.0 | 0.2 | GO:0007141 | male meiosis I(GO:0007141) |
| 0.0 | 0.9 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.0 | 0.0 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
| 0.0 | 0.6 | GO:0051290 | protein heterotetramerization(GO:0051290) |
| 0.0 | 1.0 | GO:0061462 | protein localization to lysosome(GO:0061462) |
| 0.0 | 0.1 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
| 0.0 | 0.5 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
| 0.0 | 0.5 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.0 | 0.4 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
| 0.0 | 0.3 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.0 | 0.6 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
| 0.0 | 0.8 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
| 0.0 | 1.1 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.0 | 0.4 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.0 | 0.7 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
| 0.0 | 0.2 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
| 0.0 | 1.6 | GO:0045454 | cell redox homeostasis(GO:0045454) |
| 0.0 | 0.7 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.0 | 1.0 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
| 0.0 | 1.4 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
| 0.0 | 0.3 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.0 | 0.1 | GO:0061075 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) cerebral cortex GABAergic interneuron fate commitment(GO:0021893) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
| 0.0 | 1.1 | GO:0046324 | regulation of glucose import(GO:0046324) |
| 0.0 | 1.9 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
| 0.0 | 0.3 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
| 0.0 | 0.3 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.0 | 0.2 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
| 0.0 | 0.9 | GO:0035036 | binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
| 0.0 | 0.0 | GO:0016078 | tRNA catabolic process(GO:0016078) |
| 0.0 | 0.1 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
| 0.0 | 0.7 | GO:0006006 | glucose metabolic process(GO:0006006) |
| 0.0 | 0.1 | GO:0006999 | nuclear pore organization(GO:0006999) |
| 0.0 | 0.1 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
| 0.0 | 0.2 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
| 0.0 | 0.5 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
| 0.0 | 0.2 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
| 0.0 | 0.1 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
| 0.0 | 1.8 | GO:0035150 | regulation of tube size(GO:0035150) regulation of blood vessel size(GO:0050880) |
| 0.0 | 0.4 | GO:0019985 | translesion synthesis(GO:0019985) |
| 0.0 | 0.5 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.0 | 1.6 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
| 0.0 | 0.2 | GO:0009098 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.0 | 0.1 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
| 0.0 | 1.1 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
| 0.0 | 0.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.0 | 0.3 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
| 0.0 | 0.2 | GO:0007130 | synaptonemal complex assembly(GO:0007130) synaptonemal complex organization(GO:0070193) |
| 0.0 | 0.7 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
| 0.0 | 0.2 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
| 0.0 | 0.1 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.0 | 0.9 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
| 0.0 | 0.3 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
| 0.0 | 0.1 | GO:0048209 | regulation of vesicle targeting, to, from or within Golgi(GO:0048209) |
| 0.0 | 1.1 | GO:0009063 | cellular amino acid catabolic process(GO:0009063) |
| 0.0 | 0.3 | GO:0006491 | N-glycan processing(GO:0006491) |
| 0.0 | 0.1 | GO:0009072 | aromatic amino acid family metabolic process(GO:0009072) |
| 0.0 | 0.2 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
| 0.0 | 0.2 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
| 0.0 | 0.3 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 0.0 | 0.2 | GO:0034109 | homotypic cell-cell adhesion(GO:0034109) |
| 0.0 | 0.2 | GO:0046415 | urate metabolic process(GO:0046415) |
| 0.0 | 0.4 | GO:1900077 | negative regulation of cellular response to insulin stimulus(GO:1900077) |
| 0.0 | 0.3 | GO:0060143 | positive regulation of syncytium formation by plasma membrane fusion(GO:0060143) |
| 0.0 | 1.1 | GO:0070527 | platelet aggregation(GO:0070527) |
| 0.0 | 0.5 | GO:0060008 | Sertoli cell differentiation(GO:0060008) |
| 0.0 | 0.8 | GO:0046902 | regulation of mitochondrial membrane permeability(GO:0046902) |
| 0.0 | 0.1 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.0 | 0.4 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
| 0.0 | 0.5 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
| 0.0 | 0.2 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
| 0.0 | 0.6 | GO:0016925 | protein sumoylation(GO:0016925) |
| 0.0 | 0.4 | GO:0048477 | oogenesis(GO:0048477) |
| 0.0 | 0.3 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
| 0.0 | 0.2 | GO:0019395 | fatty acid oxidation(GO:0019395) |
| 0.0 | 0.9 | GO:0051289 | protein homotetramerization(GO:0051289) |
| 0.0 | 0.2 | GO:0061732 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.0 | 0.1 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.0 | 0.2 | GO:0032212 | positive regulation of telomere maintenance via telomerase(GO:0032212) |
| 0.0 | 0.7 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
| 0.0 | 0.5 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
| 0.0 | 0.2 | GO:0051894 | positive regulation of focal adhesion assembly(GO:0051894) positive regulation of adherens junction organization(GO:1903393) |
| 0.0 | 0.3 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
| 0.0 | 0.9 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
| 0.0 | 0.2 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
| 0.0 | 0.4 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.0 | 0.2 | GO:0072010 | glomerular epithelium development(GO:0072010) |
| 0.0 | 0.5 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
| 0.0 | 0.2 | GO:0001945 | lymph vessel development(GO:0001945) |
| 0.0 | 0.2 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.0 | 0.2 | GO:0007041 | lysosomal transport(GO:0007041) |
| 0.0 | 0.1 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.0 | 0.1 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
| 0.0 | 0.2 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
| 0.0 | 0.1 | GO:1990034 | calcium ion export(GO:1901660) calcium ion export from cell(GO:1990034) |
| 0.0 | 0.4 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
| 0.0 | 0.2 | GO:0014002 | astrocyte development(GO:0014002) |
| 0.0 | 0.1 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.0 | 0.0 | GO:0060347 | heart trabecula formation(GO:0060347) |
| 0.0 | 0.1 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.0 | 0.1 | GO:0009174 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.0 | 0.1 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
| 0.0 | 0.1 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.0 | 0.0 | GO:0030167 | proteoglycan catabolic process(GO:0030167) heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.0 | 0.3 | GO:0032456 | endocytic recycling(GO:0032456) |
| 0.0 | 0.2 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
| 0.0 | 0.2 | GO:0031648 | protein destabilization(GO:0031648) |
| 0.0 | 0.3 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 0.0 | 0.2 | GO:0006213 | pyrimidine nucleoside metabolic process(GO:0006213) |
| 0.0 | 0.2 | GO:0003170 | heart valve development(GO:0003170) |
| 0.0 | 0.2 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.0 | 0.1 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
| 0.0 | 0.4 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.0 | 0.1 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
| 0.0 | 0.2 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
| 0.0 | 0.1 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.0 | 0.1 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
| 0.0 | 0.1 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.0 | 0.1 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
| 0.0 | 0.2 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
| 0.0 | 0.5 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.3 | 7.0 | GO:0071953 | elastic fiber(GO:0071953) |
| 1.5 | 5.8 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
| 1.4 | 4.2 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
| 1.1 | 1.1 | GO:0097427 | microtubule bundle(GO:0097427) |
| 1.1 | 6.6 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 1.0 | 3.1 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
| 1.0 | 3.1 | GO:0036387 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
| 0.9 | 4.4 | GO:0031262 | Ndc80 complex(GO:0031262) |
| 0.8 | 3.0 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 0.7 | 5.2 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 0.7 | 3.7 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.7 | 2.9 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
| 0.7 | 3.4 | GO:0033010 | paranodal junction(GO:0033010) |
| 0.7 | 2.7 | GO:0032021 | NELF complex(GO:0032021) |
| 0.6 | 2.5 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.6 | 5.8 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.5 | 5.5 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
| 0.5 | 1.6 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
| 0.5 | 24.1 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
| 0.4 | 1.3 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 0.4 | 6.3 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
| 0.4 | 1.7 | GO:0002111 | BRCA2-BRAF35 complex(GO:0002111) |
| 0.4 | 6.6 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.4 | 2.5 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
| 0.4 | 3.3 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
| 0.4 | 4.5 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 0.4 | 1.6 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 0.4 | 2.7 | GO:0097452 | GAIT complex(GO:0097452) |
| 0.4 | 3.2 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.4 | 5.0 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
| 0.3 | 0.3 | GO:1990415 | Pex17p-Pex14p docking complex(GO:1990415) peroxisomal importomer complex(GO:1990429) |
| 0.3 | 2.0 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 0.3 | 2.3 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
| 0.3 | 1.3 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
| 0.3 | 1.0 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 0.3 | 2.8 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.3 | 1.9 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.3 | 3.6 | GO:0022626 | cytosolic ribosome(GO:0022626) |
| 0.3 | 2.6 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.3 | 1.7 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
| 0.3 | 2.8 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
| 0.3 | 7.0 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.3 | 2.0 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.3 | 1.7 | GO:0071986 | Ragulator complex(GO:0071986) |
| 0.3 | 0.8 | GO:0030934 | collagen type XII trimer(GO:0005595) anchoring collagen complex(GO:0030934) |
| 0.3 | 0.8 | GO:0000801 | central element(GO:0000801) |
| 0.3 | 2.5 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 0.3 | 2.7 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.3 | 9.9 | GO:0035371 | microtubule plus-end(GO:0035371) |
| 0.3 | 1.0 | GO:0045098 | type III intermediate filament(GO:0045098) |
| 0.3 | 14.6 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
| 0.2 | 1.2 | GO:0042583 | chromaffin granule(GO:0042583) |
| 0.2 | 2.2 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
| 0.2 | 0.7 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
| 0.2 | 2.6 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 0.2 | 0.9 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 0.2 | 0.9 | GO:0070552 | BRISC complex(GO:0070552) |
| 0.2 | 1.6 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 0.2 | 0.7 | GO:0097450 | astrocyte end-foot(GO:0097450) |
| 0.2 | 0.7 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
| 0.2 | 1.3 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 0.2 | 4.0 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 0.2 | 11.2 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 0.2 | 1.3 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
| 0.2 | 2.0 | GO:0042599 | lamellar body(GO:0042599) |
| 0.2 | 1.6 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.2 | 0.6 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 0.2 | 2.7 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
| 0.2 | 0.4 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.2 | 1.0 | GO:0034715 | U7 snRNP(GO:0005683) pICln-Sm protein complex(GO:0034715) |
| 0.2 | 1.0 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
| 0.2 | 0.6 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
| 0.2 | 0.7 | GO:0001674 | female germ cell nucleus(GO:0001674) |
| 0.2 | 0.9 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
| 0.2 | 1.3 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
| 0.2 | 1.7 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) |
| 0.2 | 1.1 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
| 0.2 | 0.2 | GO:0045179 | apical cortex(GO:0045179) |
| 0.2 | 0.4 | GO:1990812 | growth cone filopodium(GO:1990812) |
| 0.2 | 2.3 | GO:0005839 | proteasome core complex(GO:0005839) |
| 0.2 | 0.9 | GO:1990246 | uniplex complex(GO:1990246) |
| 0.2 | 2.9 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.2 | 1.6 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 0.2 | 1.1 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.2 | 1.2 | GO:0070469 | respiratory chain(GO:0070469) |
| 0.2 | 1.4 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
| 0.2 | 2.5 | GO:0031105 | septin complex(GO:0031105) |
| 0.2 | 1.5 | GO:0030478 | actin cap(GO:0030478) |
| 0.2 | 0.7 | GO:0089701 | U2AF(GO:0089701) |
| 0.2 | 0.3 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
| 0.2 | 1.1 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 0.2 | 0.8 | GO:1990745 | EARP complex(GO:1990745) |
| 0.2 | 0.6 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.2 | 1.1 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
| 0.2 | 0.6 | GO:0097574 | lateral part of cell(GO:0097574) basolateral part of cell(GO:1990794) rod bipolar cell terminal bouton(GO:1990795) |
| 0.2 | 8.3 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
| 0.2 | 0.8 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
| 0.2 | 0.5 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.1 | 1.5 | GO:0046930 | pore complex(GO:0046930) |
| 0.1 | 1.5 | GO:0070852 | cell body fiber(GO:0070852) |
| 0.1 | 1.6 | GO:0043203 | axon hillock(GO:0043203) |
| 0.1 | 0.7 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.1 | 0.9 | GO:0030061 | mitochondrial crista(GO:0030061) |
| 0.1 | 0.6 | GO:0005594 | FACIT collagen trimer(GO:0005593) collagen type IX trimer(GO:0005594) |
| 0.1 | 1.0 | GO:0005828 | kinetochore microtubule(GO:0005828) |
| 0.1 | 0.6 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 0.1 | 2.3 | GO:0036038 | MKS complex(GO:0036038) |
| 0.1 | 0.7 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
| 0.1 | 0.7 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
| 0.1 | 2.3 | GO:0005605 | basal lamina(GO:0005605) |
| 0.1 | 1.5 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
| 0.1 | 0.4 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
| 0.1 | 1.2 | GO:0000974 | Prp19 complex(GO:0000974) |
| 0.1 | 1.1 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
| 0.1 | 0.9 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 0.1 | 0.8 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.1 | 2.4 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 0.1 | 0.4 | GO:0001652 | granular component(GO:0001652) |
| 0.1 | 1.2 | GO:0000243 | commitment complex(GO:0000243) |
| 0.1 | 0.8 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.1 | 10.0 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 0.1 | 2.9 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.1 | 2.6 | GO:0016514 | SWI/SNF complex(GO:0016514) |
| 0.1 | 9.2 | GO:0015934 | large ribosomal subunit(GO:0015934) |
| 0.1 | 0.6 | GO:0071817 | MMXD complex(GO:0071817) CIA complex(GO:0097361) |
| 0.1 | 0.4 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
| 0.1 | 0.6 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) cytoplasmic side of lysosomal membrane(GO:0098574) |
| 0.1 | 0.5 | GO:0005775 | vacuolar lumen(GO:0005775) |
| 0.1 | 1.5 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
| 0.1 | 1.2 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
| 0.1 | 1.5 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
| 0.1 | 1.1 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.1 | 2.0 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.1 | 0.8 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 0.1 | 3.9 | GO:0000788 | nuclear nucleosome(GO:0000788) |
| 0.1 | 0.9 | GO:0097413 | Lewy body(GO:0097413) |
| 0.1 | 8.4 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.1 | 0.6 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.1 | 1.4 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
| 0.1 | 1.3 | GO:0045095 | keratin filament(GO:0045095) |
| 0.1 | 1.1 | GO:0001739 | sex chromatin(GO:0001739) |
| 0.1 | 8.2 | GO:0005657 | replication fork(GO:0005657) |
| 0.1 | 0.8 | GO:0097449 | astrocyte projection(GO:0097449) |
| 0.1 | 0.3 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 0.1 | 4.7 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
| 0.1 | 1.5 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.1 | 1.6 | GO:0005771 | multivesicular body(GO:0005771) |
| 0.1 | 2.7 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.1 | 1.6 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.1 | 0.7 | GO:0005638 | lamin filament(GO:0005638) |
| 0.1 | 1.2 | GO:0042612 | MHC class I protein complex(GO:0042612) |
| 0.1 | 0.8 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.1 | 15.2 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 0.1 | 0.5 | GO:1990130 | Iml1 complex(GO:1990130) |
| 0.1 | 1.1 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.1 | 3.1 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
| 0.1 | 0.9 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.1 | 1.8 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
| 0.1 | 0.3 | GO:0019815 | B cell receptor complex(GO:0019815) |
| 0.1 | 0.5 | GO:0033270 | paranode region of axon(GO:0033270) |
| 0.1 | 1.0 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.1 | 1.5 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
| 0.1 | 1.0 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.1 | 5.6 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.1 | 0.4 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
| 0.1 | 1.0 | GO:0098644 | complex of collagen trimers(GO:0098644) |
| 0.1 | 0.6 | GO:0097255 | R2TP complex(GO:0097255) |
| 0.1 | 0.5 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.1 | 8.1 | GO:0000922 | spindle pole(GO:0000922) |
| 0.1 | 0.8 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.1 | 0.5 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 0.1 | 0.7 | GO:0042382 | paraspeckles(GO:0042382) |
| 0.1 | 4.9 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
| 0.1 | 0.3 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.1 | 0.2 | GO:0070069 | cytochrome complex(GO:0070069) |
| 0.1 | 0.9 | GO:0031931 | TORC1 complex(GO:0031931) |
| 0.1 | 1.1 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 0.1 | 3.0 | GO:0000786 | nucleosome(GO:0000786) |
| 0.1 | 0.2 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) cytoplasmic side of early endosome membrane(GO:0098559) |
| 0.1 | 0.3 | GO:0008305 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
| 0.1 | 0.9 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.1 | 0.9 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.1 | 3.4 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
| 0.1 | 18.9 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
| 0.1 | 2.8 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.1 | 1.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.1 | 0.7 | GO:0045252 | dihydrolipoyl dehydrogenase complex(GO:0045240) oxoglutarate dehydrogenase complex(GO:0045252) |
| 0.1 | 0.9 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 0.1 | 1.5 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
| 0.1 | 1.0 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.1 | 0.8 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.1 | 0.4 | GO:0005916 | fascia adherens(GO:0005916) |
| 0.1 | 1.1 | GO:0031012 | extracellular matrix(GO:0031012) |
| 0.1 | 0.7 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
| 0.1 | 1.0 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 0.1 | 0.1 | GO:0097637 | integral component of vacuolar membrane(GO:0031166) intrinsic component of vacuolar membrane(GO:0031310) intrinsic component of autophagosome membrane(GO:0097636) integral component of autophagosome membrane(GO:0097637) |
| 0.1 | 0.3 | GO:1990357 | terminal web(GO:1990357) |
| 0.1 | 2.5 | GO:0005811 | lipid particle(GO:0005811) |
| 0.1 | 1.5 | GO:0032993 | protein-DNA complex(GO:0032993) |
| 0.1 | 24.6 | GO:0005667 | transcription factor complex(GO:0005667) |
| 0.1 | 0.8 | GO:0097542 | ciliary tip(GO:0097542) |
| 0.1 | 1.9 | GO:0019866 | organelle inner membrane(GO:0019866) |
| 0.1 | 0.2 | GO:1990047 | spindle matrix(GO:1990047) |
| 0.1 | 0.6 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 0.1 | 0.4 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 0.1 | 3.1 | GO:0001669 | acrosomal vesicle(GO:0001669) |
| 0.1 | 0.8 | GO:0010369 | chromocenter(GO:0010369) |
| 0.1 | 0.2 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.1 | 0.9 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
| 0.1 | 1.5 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.1 | 0.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.1 | 2.1 | GO:0005844 | polysome(GO:0005844) |
| 0.1 | 0.3 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
| 0.1 | 0.6 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 0.1 | 0.8 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.1 | 0.7 | GO:0035869 | ciliary transition zone(GO:0035869) |
| 0.1 | 0.3 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.0 | 0.2 | GO:0031523 | Myb complex(GO:0031523) |
| 0.0 | 0.4 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.0 | 44.1 | GO:0005615 | extracellular space(GO:0005615) |
| 0.0 | 4.3 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
| 0.0 | 1.0 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.0 | 0.1 | GO:0043073 | germ cell nucleus(GO:0043073) |
| 0.0 | 0.8 | GO:0005840 | ribosome(GO:0005840) |
| 0.0 | 0.5 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
| 0.0 | 0.7 | GO:0032039 | integrator complex(GO:0032039) |
| 0.0 | 0.4 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
| 0.0 | 0.3 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
| 0.0 | 0.3 | GO:0005770 | late endosome(GO:0005770) |
| 0.0 | 4.6 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
| 0.0 | 3.7 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
| 0.0 | 0.6 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.0 | 1.1 | GO:0032420 | stereocilium(GO:0032420) |
| 0.0 | 0.4 | GO:0005719 | nuclear euchromatin(GO:0005719) |
| 0.0 | 0.1 | GO:0005652 | nuclear lamina(GO:0005652) |
| 0.0 | 0.1 | GO:0032389 | MutLalpha complex(GO:0032389) |
| 0.0 | 0.1 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
| 0.0 | 2.8 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
| 0.0 | 0.2 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
| 0.0 | 0.3 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
| 0.0 | 0.2 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
| 0.0 | 0.9 | GO:0097546 | ciliary base(GO:0097546) |
| 0.0 | 0.6 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.0 | 0.2 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
| 0.0 | 2.0 | GO:0005901 | caveola(GO:0005901) |
| 0.0 | 1.3 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.0 | 0.2 | GO:0030914 | STAGA complex(GO:0030914) |
| 0.0 | 7.9 | GO:0005925 | focal adhesion(GO:0005925) |
| 0.0 | 0.2 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
| 0.0 | 0.6 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.0 | 0.5 | GO:0036126 | sperm flagellum(GO:0036126) |
| 0.0 | 0.7 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
| 0.0 | 0.7 | GO:0016592 | mediator complex(GO:0016592) |
| 0.0 | 0.4 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
| 0.0 | 0.1 | GO:0072687 | meiotic spindle(GO:0072687) |
| 0.0 | 0.1 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
| 0.0 | 0.1 | GO:0032156 | septin cytoskeleton(GO:0032156) |
| 0.0 | 2.2 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
| 0.0 | 0.6 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.0 | 0.1 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
| 0.0 | 0.2 | GO:0031011 | Ino80 complex(GO:0031011) |
| 0.0 | 0.1 | GO:0005682 | U5 snRNP(GO:0005682) |
| 0.0 | 0.0 | GO:0034272 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
| 0.0 | 0.4 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 0.0 | 0.2 | GO:0070938 | contractile ring(GO:0070938) |
| 0.0 | 2.5 | GO:0031965 | nuclear membrane(GO:0031965) |
| 0.0 | 1.1 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
| 0.0 | 14.3 | GO:0005739 | mitochondrion(GO:0005739) |
| 0.0 | 0.1 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.0 | 0.6 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.0 | 0.1 | GO:0002102 | podosome(GO:0002102) |
| 0.0 | 0.1 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
| 0.0 | 1.1 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
| 0.0 | 3.2 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
| 0.0 | 0.6 | GO:0000793 | condensed chromosome(GO:0000793) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.3 | 13.2 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
| 2.9 | 8.7 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
| 2.5 | 7.6 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 2.4 | 7.1 | GO:0033680 | ATP-dependent DNA/RNA helicase activity(GO:0033680) |
| 1.9 | 5.6 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
| 1.7 | 7.0 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
| 1.5 | 8.9 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 1.4 | 4.2 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
| 1.4 | 9.7 | GO:0031419 | cobalamin binding(GO:0031419) |
| 1.3 | 5.0 | GO:0042806 | fucose binding(GO:0042806) |
| 1.2 | 4.9 | GO:0001851 | complement component C3b binding(GO:0001851) |
| 1.1 | 4.3 | GO:0016708 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
| 1.0 | 5.2 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
| 1.0 | 3.1 | GO:0000992 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) RNA polymerase III transcription factor activity, sequence-specific DNA binding(GO:0001034) |
| 1.0 | 4.1 | GO:0004064 | arylesterase activity(GO:0004064) |
| 1.0 | 3.0 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
| 1.0 | 10.9 | GO:0008430 | selenium binding(GO:0008430) |
| 0.9 | 3.6 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
| 0.8 | 6.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.8 | 2.3 | GO:0004510 | tryptophan 5-monooxygenase activity(GO:0004510) |
| 0.8 | 3.0 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
| 0.7 | 2.2 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
| 0.7 | 2.1 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
| 0.7 | 2.8 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
| 0.7 | 15.3 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.6 | 2.5 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.6 | 1.9 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
| 0.6 | 1.9 | GO:0046997 | sarcosine dehydrogenase activity(GO:0008480) oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
| 0.6 | 2.4 | GO:0003844 | 1,4-alpha-glucan branching enzyme activity(GO:0003844) |
| 0.6 | 2.4 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
| 0.6 | 2.3 | GO:0032027 | myosin light chain binding(GO:0032027) |
| 0.6 | 2.9 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
| 0.6 | 1.7 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
| 0.6 | 1.1 | GO:0034185 | apolipoprotein binding(GO:0034185) |
| 0.6 | 1.7 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
| 0.6 | 3.3 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
| 0.5 | 4.2 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
| 0.5 | 1.6 | GO:0005110 | frizzled-2 binding(GO:0005110) |
| 0.5 | 3.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
| 0.5 | 1.6 | GO:0008311 | double-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008311) |
| 0.5 | 1.6 | GO:0035651 | AP-1 adaptor complex binding(GO:0035650) AP-3 adaptor complex binding(GO:0035651) |
| 0.5 | 1.6 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
| 0.5 | 1.6 | GO:0036470 | tyrosine 3-monooxygenase activator activity(GO:0036470) L-dopa decarboxylase activator activity(GO:0036478) |
| 0.5 | 1.5 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
| 0.5 | 3.4 | GO:0015091 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
| 0.5 | 3.4 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.5 | 2.4 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
| 0.5 | 1.4 | GO:0003977 | UDP-N-acetylglucosamine diphosphorylase activity(GO:0003977) |
| 0.5 | 1.9 | GO:0050544 | arachidonic acid binding(GO:0050544) |
| 0.5 | 2.8 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 0.5 | 1.8 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.5 | 1.4 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
| 0.5 | 3.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 0.4 | 1.8 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
| 0.4 | 8.8 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
| 0.4 | 6.6 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.4 | 3.4 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
| 0.4 | 1.3 | GO:0030172 | troponin C binding(GO:0030172) |
| 0.4 | 3.8 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.4 | 2.1 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
| 0.4 | 3.4 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.4 | 1.2 | GO:0030984 | kininogen binding(GO:0030984) |
| 0.4 | 4.1 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.4 | 4.4 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
| 0.4 | 1.6 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 0.4 | 3.6 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 0.4 | 1.6 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
| 0.4 | 3.1 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
| 0.4 | 2.3 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
| 0.4 | 1.6 | GO:0038049 | glucocorticoid receptor activity(GO:0004883) transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
| 0.4 | 6.6 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
| 0.4 | 1.9 | GO:0043532 | angiostatin binding(GO:0043532) |
| 0.4 | 0.8 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
| 0.4 | 3.1 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
| 0.4 | 0.8 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
| 0.4 | 2.6 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
| 0.4 | 1.5 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
| 0.4 | 7.3 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
| 0.4 | 5.4 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
| 0.4 | 0.7 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
| 0.4 | 10.4 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
| 0.4 | 0.7 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 0.4 | 2.1 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
| 0.3 | 1.0 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
| 0.3 | 5.8 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
| 0.3 | 2.0 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.3 | 1.3 | GO:0016842 | amidine-lyase activity(GO:0016842) |
| 0.3 | 1.0 | GO:0051747 | cytosine C-5 DNA demethylase activity(GO:0051747) |
| 0.3 | 1.0 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
| 0.3 | 0.7 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
| 0.3 | 4.7 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.3 | 1.0 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 0.3 | 1.0 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 0.3 | 1.0 | GO:0035605 | peptidyl-cysteine S-nitrosylase activity(GO:0035605) |
| 0.3 | 0.6 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
| 0.3 | 1.0 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
| 0.3 | 2.8 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.3 | 0.9 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
| 0.3 | 0.9 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
| 0.3 | 0.9 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
| 0.3 | 1.2 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 0.3 | 1.5 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
| 0.3 | 1.5 | GO:0019770 | IgG receptor activity(GO:0019770) |
| 0.3 | 4.7 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 0.3 | 1.4 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
| 0.3 | 1.4 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.3 | 2.5 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
| 0.3 | 1.7 | GO:0005047 | signal recognition particle binding(GO:0005047) |
| 0.3 | 2.0 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
| 0.3 | 0.8 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 0.3 | 0.8 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
| 0.3 | 2.1 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 0.3 | 1.3 | GO:0004342 | glucosamine-6-phosphate deaminase activity(GO:0004342) |
| 0.3 | 0.8 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
| 0.3 | 1.0 | GO:1990254 | keratin filament binding(GO:1990254) |
| 0.3 | 1.3 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 0.3 | 0.8 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) |
| 0.3 | 0.8 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
| 0.3 | 0.8 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
| 0.3 | 8.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.3 | 0.8 | GO:0046911 | hydroxyapatite binding(GO:0046848) metal chelating activity(GO:0046911) phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
| 0.3 | 1.0 | GO:0008802 | betaine-aldehyde dehydrogenase activity(GO:0008802) |
| 0.2 | 2.2 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.2 | 1.0 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
| 0.2 | 0.7 | GO:0003979 | UDP-glucose 6-dehydrogenase activity(GO:0003979) |
| 0.2 | 0.7 | GO:0004335 | galactokinase activity(GO:0004335) |
| 0.2 | 1.5 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
| 0.2 | 1.7 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
| 0.2 | 0.7 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
| 0.2 | 5.1 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
| 0.2 | 1.5 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.2 | 0.7 | GO:0016501 | prostacyclin receptor activity(GO:0016501) |
| 0.2 | 2.7 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.2 | 2.2 | GO:1990446 | U1 snRNP binding(GO:1990446) |
| 0.2 | 0.7 | GO:0004454 | ketohexokinase activity(GO:0004454) |
| 0.2 | 0.9 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
| 0.2 | 2.8 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.2 | 0.9 | GO:0070404 | NADH binding(GO:0070404) |
| 0.2 | 2.5 | GO:0036310 | annealing helicase activity(GO:0036310) |
| 0.2 | 0.9 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
| 0.2 | 1.4 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 0.2 | 2.9 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
| 0.2 | 0.9 | GO:0036468 | aromatic-L-amino-acid decarboxylase activity(GO:0004058) L-dopa decarboxylase activity(GO:0036468) |
| 0.2 | 0.7 | GO:0016015 | morphogen activity(GO:0016015) |
| 0.2 | 0.9 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
| 0.2 | 3.9 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
| 0.2 | 1.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.2 | 0.6 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
| 0.2 | 7.2 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.2 | 1.2 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 0.2 | 0.8 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
| 0.2 | 1.2 | GO:0050897 | cobalt ion binding(GO:0050897) |
| 0.2 | 3.5 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.2 | 0.6 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.2 | 1.1 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.2 | 1.3 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
| 0.2 | 0.2 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
| 0.2 | 4.1 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.2 | 0.9 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 0.2 | 1.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 0.2 | 1.7 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
| 0.2 | 0.5 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
| 0.2 | 0.7 | GO:0004046 | aminoacylase activity(GO:0004046) |
| 0.2 | 0.5 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 0.2 | 2.0 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
| 0.2 | 1.2 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
| 0.2 | 2.9 | GO:0005044 | scavenger receptor activity(GO:0005044) |
| 0.2 | 2.7 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.2 | 1.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.2 | 7.7 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.2 | 1.2 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
| 0.2 | 0.5 | GO:0019779 | Atg12 activating enzyme activity(GO:0019778) Atg8 activating enzyme activity(GO:0019779) |
| 0.2 | 1.3 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
| 0.2 | 0.7 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 0.2 | 1.0 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 0.2 | 7.0 | GO:0016209 | antioxidant activity(GO:0016209) |
| 0.2 | 1.0 | GO:0019841 | retinol binding(GO:0019841) |
| 0.2 | 0.6 | GO:0016531 | copper chaperone activity(GO:0016531) |
| 0.2 | 0.5 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
| 0.2 | 1.1 | GO:0015925 | galactosidase activity(GO:0015925) |
| 0.2 | 0.5 | GO:0001729 | ceramide kinase activity(GO:0001729) |
| 0.2 | 0.6 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
| 0.2 | 0.3 | GO:0098631 | protein binding involved in cell adhesion(GO:0098631) |
| 0.2 | 0.8 | GO:0034711 | inhibin binding(GO:0034711) |
| 0.2 | 1.1 | GO:0015099 | nickel cation transmembrane transporter activity(GO:0015099) |
| 0.2 | 0.8 | GO:0048039 | ubiquinone binding(GO:0048039) |
| 0.2 | 0.3 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
| 0.1 | 1.5 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.1 | 0.7 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
| 0.1 | 0.6 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
| 0.1 | 0.6 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
| 0.1 | 0.7 | GO:0008494 | translation activator activity(GO:0008494) |
| 0.1 | 0.6 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 0.1 | 0.6 | GO:0004921 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
| 0.1 | 1.0 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
| 0.1 | 0.4 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.1 | 0.7 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
| 0.1 | 0.5 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.1 | 0.4 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
| 0.1 | 5.2 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
| 0.1 | 0.9 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 0.1 | 0.7 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
| 0.1 | 0.4 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
| 0.1 | 1.6 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
| 0.1 | 0.8 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.1 | 2.2 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 0.1 | 1.3 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
| 0.1 | 5.3 | GO:0005179 | hormone activity(GO:0005179) |
| 0.1 | 1.0 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
| 0.1 | 1.5 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
| 0.1 | 0.4 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
| 0.1 | 0.9 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
| 0.1 | 21.5 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.1 | 0.4 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
| 0.1 | 0.4 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
| 0.1 | 0.6 | GO:0045545 | syndecan binding(GO:0045545) |
| 0.1 | 0.8 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 0.1 | 3.3 | GO:0001223 | transcription coactivator binding(GO:0001223) |
| 0.1 | 0.7 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
| 0.1 | 2.4 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.1 | 0.7 | GO:0009374 | biotin binding(GO:0009374) |
| 0.1 | 0.6 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
| 0.1 | 1.6 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
| 0.1 | 0.7 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.1 | 4.0 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.1 | 1.9 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.1 | 0.1 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
| 0.1 | 0.4 | GO:0070538 | propanoyl-CoA C-acyltransferase activity(GO:0033814) propionyl-CoA C2-trimethyltridecanoyltransferase activity(GO:0050632) oleic acid binding(GO:0070538) phosphatidylethanolamine transporter activity(GO:1904121) |
| 0.1 | 0.6 | GO:0043426 | MRF binding(GO:0043426) |
| 0.1 | 1.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.1 | 4.1 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
| 0.1 | 1.6 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
| 0.1 | 0.3 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
| 0.1 | 0.7 | GO:0008242 | omega peptidase activity(GO:0008242) |
| 0.1 | 1.0 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
| 0.1 | 0.5 | GO:0042731 | PH domain binding(GO:0042731) |
| 0.1 | 0.8 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
| 0.1 | 0.9 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.1 | 1.2 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
| 0.1 | 0.1 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
| 0.1 | 2.5 | GO:0000217 | DNA secondary structure binding(GO:0000217) |
| 0.1 | 0.7 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
| 0.1 | 0.9 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 0.1 | 0.8 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 0.1 | 0.3 | GO:0009881 | photoreceptor activity(GO:0009881) |
| 0.1 | 1.0 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 0.1 | 1.9 | GO:0019789 | SUMO transferase activity(GO:0019789) |
| 0.1 | 3.9 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
| 0.1 | 0.8 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
| 0.1 | 0.3 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 0.1 | 0.3 | GO:0035939 | microsatellite binding(GO:0035939) |
| 0.1 | 1.0 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 0.1 | 1.0 | GO:0009055 | electron carrier activity(GO:0009055) |
| 0.1 | 0.7 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
| 0.1 | 2.8 | GO:0051183 | vitamin transporter activity(GO:0051183) |
| 0.1 | 0.4 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
| 0.1 | 0.6 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
| 0.1 | 1.1 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
| 0.1 | 0.4 | GO:0031685 | adenosine receptor binding(GO:0031685) |
| 0.1 | 0.4 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
| 0.1 | 0.3 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
| 0.1 | 0.3 | GO:0050436 | microfibril binding(GO:0050436) |
| 0.1 | 1.5 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
| 0.1 | 0.9 | GO:0004017 | adenylate kinase activity(GO:0004017) |
| 0.1 | 0.2 | GO:0032052 | bile acid binding(GO:0032052) |
| 0.1 | 0.3 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
| 0.1 | 7.5 | GO:0005178 | integrin binding(GO:0005178) |
| 0.1 | 0.6 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.1 | 1.9 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.1 | 0.2 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
| 0.1 | 2.0 | GO:0003714 | transcription corepressor activity(GO:0003714) |
| 0.1 | 1.1 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 0.1 | 0.2 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
| 0.1 | 0.3 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
| 0.1 | 0.6 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
| 0.1 | 0.7 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 0.1 | 0.2 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.1 | 0.4 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
| 0.1 | 1.5 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 0.1 | 0.4 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
| 0.1 | 0.4 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
| 0.1 | 2.7 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
| 0.1 | 0.1 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
| 0.1 | 0.8 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.1 | 0.7 | GO:0070411 | I-SMAD binding(GO:0070411) |
| 0.1 | 1.8 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 0.1 | 0.4 | GO:0000298 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
| 0.1 | 1.0 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
| 0.1 | 0.3 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
| 0.1 | 0.3 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
| 0.1 | 0.7 | GO:0019531 | secondary active sulfate transmembrane transporter activity(GO:0008271) sulfate transmembrane transporter activity(GO:0015116) oxalate transmembrane transporter activity(GO:0019531) |
| 0.1 | 0.3 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.1 | 3.0 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
| 0.1 | 1.2 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
| 0.1 | 0.7 | GO:0046977 | beta-2-microglobulin binding(GO:0030881) TAP binding(GO:0046977) |
| 0.1 | 0.1 | GO:0004954 | icosanoid receptor activity(GO:0004953) prostanoid receptor activity(GO:0004954) prostaglandin receptor activity(GO:0004955) |
| 0.1 | 0.2 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
| 0.1 | 0.2 | GO:0004966 | galanin receptor activity(GO:0004966) |
| 0.1 | 0.9 | GO:0031702 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
| 0.1 | 0.2 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 0.1 | 0.4 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
| 0.1 | 0.2 | GO:0070736 | protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) |
| 0.1 | 2.0 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.1 | 1.4 | GO:0051087 | chaperone binding(GO:0051087) |
| 0.1 | 0.7 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
| 0.1 | 0.7 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
| 0.1 | 0.3 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
| 0.1 | 0.7 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
| 0.1 | 2.0 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.1 | 0.6 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 0.1 | 0.3 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
| 0.1 | 0.4 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
| 0.1 | 0.4 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
| 0.1 | 0.9 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
| 0.1 | 0.6 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 0.1 | 2.3 | GO:0051082 | unfolded protein binding(GO:0051082) |
| 0.1 | 0.2 | GO:0070891 | peptidoglycan binding(GO:0042834) lipoteichoic acid binding(GO:0070891) |
| 0.1 | 0.6 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
| 0.1 | 0.4 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.1 | 0.9 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 0.1 | 0.3 | GO:0097643 | amylin receptor activity(GO:0097643) |
| 0.1 | 0.6 | GO:0048018 | receptor agonist activity(GO:0048018) |
| 0.1 | 0.2 | GO:0080084 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) 5S rDNA binding(GO:0080084) |
| 0.1 | 0.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.0 | 0.3 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 0.0 | 0.6 | GO:0042605 | peptide antigen binding(GO:0042605) |
| 0.0 | 0.8 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
| 0.0 | 1.3 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.0 | 2.1 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
| 0.0 | 0.8 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
| 0.0 | 0.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.0 | 2.9 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
| 0.0 | 0.4 | GO:0002162 | dystroglycan binding(GO:0002162) |
| 0.0 | 0.1 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
| 0.0 | 1.3 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
| 0.0 | 0.5 | GO:0005537 | mannose binding(GO:0005537) |
| 0.0 | 5.8 | GO:0001047 | core promoter binding(GO:0001047) |
| 0.0 | 0.9 | GO:0070628 | proteasome binding(GO:0070628) |
| 0.0 | 0.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.0 | 0.3 | GO:1990405 | protein antigen binding(GO:1990405) |
| 0.0 | 0.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.0 | 0.2 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
| 0.0 | 0.2 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.0 | 7.2 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
| 0.0 | 0.9 | GO:0070840 | dynein complex binding(GO:0070840) |
| 0.0 | 1.1 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.0 | 1.0 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
| 0.0 | 0.6 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
| 0.0 | 1.0 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.0 | 0.3 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.0 | 0.8 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
| 0.0 | 0.3 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.0 | 0.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.0 | 3.0 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
| 0.0 | 0.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.0 | 1.6 | GO:0008146 | sulfotransferase activity(GO:0008146) |
| 0.0 | 0.5 | GO:0042056 | chemoattractant activity(GO:0042056) |
| 0.0 | 0.2 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
| 0.0 | 0.3 | GO:0015288 | protein channel activity(GO:0015266) porin activity(GO:0015288) |
| 0.0 | 0.6 | GO:0008483 | transaminase activity(GO:0008483) |
| 0.0 | 0.2 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 0.0 | 1.2 | GO:0042162 | telomeric DNA binding(GO:0042162) |
| 0.0 | 0.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
| 0.0 | 0.1 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
| 0.0 | 0.3 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.0 | 0.3 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 0.0 | 0.5 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.0 | 1.0 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.0 | 0.2 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
| 0.0 | 0.3 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
| 0.0 | 0.5 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
| 0.0 | 0.2 | GO:0016803 | ether hydrolase activity(GO:0016803) |
| 0.0 | 0.1 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
| 0.0 | 2.1 | GO:0008186 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
| 0.0 | 0.2 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
| 0.0 | 0.2 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
| 0.0 | 0.9 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
| 0.0 | 0.7 | GO:0050840 | extracellular matrix binding(GO:0050840) |
| 0.0 | 0.4 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.0 | 0.5 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
| 0.0 | 0.1 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 0.0 | 0.1 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
| 0.0 | 0.8 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
| 0.0 | 0.3 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 0.0 | 1.3 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
| 0.0 | 0.5 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.0 | 0.7 | GO:0016836 | hydro-lyase activity(GO:0016836) |
| 0.0 | 0.5 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.0 | 0.6 | GO:0005112 | Notch binding(GO:0005112) |
| 0.0 | 0.6 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
| 0.0 | 1.4 | GO:0008013 | beta-catenin binding(GO:0008013) |
| 0.0 | 0.6 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
| 0.0 | 4.1 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
| 0.0 | 0.3 | GO:0004526 | ribonuclease P activity(GO:0004526) |
| 0.0 | 0.6 | GO:0016879 | ligase activity, forming carbon-nitrogen bonds(GO:0016879) |
| 0.0 | 0.3 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.0 | 0.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.0 | 0.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.0 | 0.1 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
| 0.0 | 0.3 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.0 | 0.1 | GO:0033142 | progesterone receptor binding(GO:0033142) |
| 0.0 | 0.1 | GO:0019961 | interferon binding(GO:0019961) |
| 0.0 | 0.4 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 0.0 | 0.1 | GO:0015410 | manganese-transporting ATPase activity(GO:0015410) |
| 0.0 | 0.5 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.0 | 0.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 0.0 | 0.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
| 0.0 | 1.5 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
| 0.0 | 1.0 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
| 0.0 | 0.3 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
| 0.0 | 0.2 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.0 | 0.4 | GO:0017069 | snRNA binding(GO:0017069) |
| 0.0 | 0.1 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
| 0.0 | 0.1 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
| 0.0 | 0.1 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
| 0.0 | 0.1 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
| 0.0 | 0.1 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
| 0.0 | 0.1 | GO:0048101 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
| 0.0 | 0.1 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
| 0.0 | 0.0 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
| 0.0 | 0.2 | GO:0031491 | nucleosome binding(GO:0031491) |
| 0.0 | 0.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.0 | 0.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.0 | 0.1 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
| 0.0 | 0.1 | GO:0004103 | choline kinase activity(GO:0004103) |
| 0.0 | 0.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.0 | 0.1 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
| 0.0 | 0.2 | GO:0008143 | poly(A) binding(GO:0008143) |
| 0.0 | 0.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.0 | 0.1 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.0 | 0.1 | GO:0033613 | activating transcription factor binding(GO:0033613) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.8 | 7.1 | SA_G2_AND_M_PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.4 | 2.9 | PID_PDGFRA_PATHWAY | PDGFR-alpha signaling pathway |
| 0.3 | 2.4 | PID_FRA_PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.3 | 12.8 | PID_FOXM1_PATHWAY | FOXM1 transcription factor network |
| 0.3 | 4.0 | PID_INTEGRIN2_PATHWAY | Beta2 integrin cell surface interactions |
| 0.2 | 1.4 | NABA_BASEMENT_MEMBRANES | Genes encoding structural components of basement membranes |
| 0.2 | 3.9 | PID_AVB3_INTEGRIN_PATHWAY | Integrins in angiogenesis |
| 0.2 | 8.6 | PID_ATR_PATHWAY | ATR signaling pathway |
| 0.2 | 0.4 | ST_PAC1_RECEPTOR_PATHWAY | PAC1 Receptor Pathway |
| 0.2 | 6.8 | PID_AURORA_A_PATHWAY | Aurora A signaling |
| 0.2 | 25.3 | NABA_ECM_GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.2 | 1.9 | PID_A6B1_A6B4_INTEGRIN_PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.2 | 1.3 | PID_S1P_META_PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
| 0.2 | 0.8 | PID_ENDOTHELIN_PATHWAY | Endothelins |
| 0.2 | 2.3 | ST_JAK_STAT_PATHWAY | Jak-STAT Pathway |
| 0.2 | 11.5 | PID_AP1_PATHWAY | AP-1 transcription factor network |
| 0.2 | 0.5 | ST_GRANULE_CELL_SURVIVAL_PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
| 0.2 | 4.7 | PID_P38_MK2_PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.1 | 5.7 | PID_ILK_PATHWAY | Integrin-linked kinase signaling |
| 0.1 | 6.7 | PID_PS1_PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.1 | 6.3 | PID_PLK1_PATHWAY | PLK1 signaling events |
| 0.1 | 12.1 | WNT_SIGNALING | Genes related to Wnt-mediated signal transduction |
| 0.1 | 1.2 | PID_IL4_2PATHWAY | IL4-mediated signaling events |
| 0.1 | 1.0 | SA_G1_AND_S_PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.1 | 0.5 | SA_REG_CASCADE_OF_CYCLIN_EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 0.1 | 2.8 | PID_TCR_CALCIUM_PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 0.1 | 3.6 | PID_BARD1_PATHWAY | BARD1 signaling events |
| 0.1 | 2.6 | PID_INTEGRIN3_PATHWAY | Beta3 integrin cell surface interactions |
| 0.1 | 1.9 | PID_S1P_S1P3_PATHWAY | S1P3 pathway |
| 0.1 | 1.2 | PID_VEGF_VEGFR_PATHWAY | VEGF and VEGFR signaling network |
| 0.1 | 2.0 | PID_FAK_PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.1 | 3.5 | PID_RXR_VDR_PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.1 | 3.0 | PID_ALK1_PATHWAY | ALK1 signaling events |
| 0.1 | 3.5 | PID_SYNDECAN_1_PATHWAY | Syndecan-1-mediated signaling events |
| 0.1 | 3.7 | PID_RHOA_PATHWAY | RhoA signaling pathway |
| 0.1 | 6.1 | PID_SMAD2_3NUCLEAR_PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 0.1 | 1.0 | PID_UPA_UPAR_PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.1 | 2.7 | PID_ALPHA_SYNUCLEIN_PATHWAY | Alpha-synuclein signaling |
| 0.1 | 3.7 | PID_TELOMERASE_PATHWAY | Regulation of Telomerase |
| 0.1 | 0.2 | PID_S1P_S1P1_PATHWAY | S1P1 pathway |
| 0.1 | 0.6 | PID_AMB2_NEUTROPHILS_PATHWAY | amb2 Integrin signaling |
| 0.1 | 2.0 | ST_MYOCYTE_AD_PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.1 | 1.6 | PID_HEDGEHOG_2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.1 | 2.1 | PID_HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.1 | 1.0 | PID_IL2_PI3K_PATHWAY | IL2 signaling events mediated by PI3K |
| 0.1 | 0.6 | ST_GA12_PATHWAY | G alpha 12 Pathway |
| 0.1 | 4.4 | PID_P73PATHWAY | p73 transcription factor network |
| 0.1 | 1.3 | PID_NFAT_TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.1 | 9.3 | NABA_ECM_REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.1 | 0.9 | PID_PRL_SIGNALING_EVENTS_PATHWAY | Signaling events mediated by PRL |
| 0.1 | 0.4 | PID_ERBB_NETWORK_PATHWAY | ErbB receptor signaling network |
| 0.1 | 3.1 | PID_RAC1_PATHWAY | RAC1 signaling pathway |
| 0.1 | 2.1 | PID_E2F_PATHWAY | E2F transcription factor network |
| 0.1 | 7.1 | NABA_ECM_AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.1 | 1.6 | PID_ANGIOPOIETIN_RECEPTOR_PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.1 | 1.6 | SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.1 | 1.0 | PID_MAPK_TRK_PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.1 | 0.6 | PID_SYNDECAN_4_PATHWAY | Syndecan-4-mediated signaling events |
| 0.1 | 1.9 | PID_AR_TF_PATHWAY | Regulation of Androgen receptor activity |
| 0.1 | 0.6 | PID_ER_NONGENOMIC_PATHWAY | Plasma membrane estrogen receptor signaling |
| 0.1 | 0.7 | PID_HDAC_CLASSIII_PATHWAY | Signaling events mediated by HDAC Class III |
| 0.1 | 0.3 | PID_INTEGRIN_CS_PATHWAY | Integrin family cell surface interactions |
| 0.1 | 0.6 | ST_G_ALPHA_S_PATHWAY | G alpha s Pathway |
| 0.0 | 0.8 | PID_SMAD2_3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.0 | 0.2 | PID_SYNDECAN_2_PATHWAY | Syndecan-2-mediated signaling events |
| 0.0 | 0.9 | PID_IL12_2PATHWAY | IL12-mediated signaling events |
| 0.0 | 0.9 | PID_INSULIN_GLUCOSE_PATHWAY | Insulin-mediated glucose transport |
| 0.0 | 0.4 | PID_IL23_PATHWAY | IL23-mediated signaling events |
| 0.0 | 1.0 | PID_AURORA_B_PATHWAY | Aurora B signaling |
| 0.0 | 1.0 | PID_CDC42_REG_PATHWAY | Regulation of CDC42 activity |
| 0.0 | 0.7 | PID_IL1_PATHWAY | IL1-mediated signaling events |
| 0.0 | 1.2 | PID_CMYB_PATHWAY | C-MYB transcription factor network |
| 0.0 | 1.0 | PID_HDAC_CLASSI_PATHWAY | Signaling events mediated by HDAC Class I |
| 0.0 | 1.1 | PID_MET_PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.0 | 0.6 | PID_REELIN_PATHWAY | Reelin signaling pathway |
| 0.0 | 0.5 | PID_NETRIN_PATHWAY | Netrin-mediated signaling events |
| 0.0 | 1.0 | PID_BETA_CATENIN_NUC_PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
| 0.0 | 0.1 | NABA_COLLAGENS | Genes encoding collagen proteins |
| 0.0 | 0.2 | PID_CIRCADIAN_PATHWAY | Circadian rhythm pathway |
| 0.0 | 0.2 | PID_MYC_PATHWAY | C-MYC pathway |
| 0.0 | 0.6 | PID_HNF3B_PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.0 | 0.1 | PID_HDAC_CLASSII_PATHWAY | Signaling events mediated by HDAC Class II |
| 0.0 | 0.1 | PID_EPHA_FWDPATHWAY | EPHA forward signaling |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.0 | 3.0 | REACTOME_PHOSPHORYLATION_OF_THE_APC_C | Genes involved in Phosphorylation of the APC/C |
| 0.9 | 4.7 | REACTOME_REGULATION_OF_COMPLEMENT_CASCADE | Genes involved in Regulation of Complement cascade |
| 0.8 | 0.8 | REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
| 0.6 | 6.4 | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
| 0.6 | 42.7 | REACTOME_RESPIRATORY_ELECTRON_TRANSPORT | Genes involved in Respiratory electron transport |
| 0.6 | 9.9 | REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.5 | 1.5 | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 0.5 | 1.8 | REACTOME_REGULATION_OF_THE_FANCONI_ANEMIA_PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
| 0.4 | 11.2 | REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
| 0.4 | 1.5 | REACTOME_ETHANOL_OXIDATION | Genes involved in Ethanol oxidation |
| 0.4 | 3.9 | REACTOME_PROLACTIN_RECEPTOR_SIGNALING | Genes involved in Prolactin receptor signaling |
| 0.3 | 3.7 | REACTOME_AMINE_DERIVED_HORMONES | Genes involved in Amine-derived hormones |
| 0.3 | 5.6 | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | Genes involved in Notch-HLH transcription pathway |
| 0.3 | 1.0 | REACTOME_EICOSANOID_LIGAND_BINDING_RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
| 0.3 | 5.2 | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_ACTIVITY_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.3 | 0.3 | REACTOME_NEF_MEDIATES_DOWN_MODULATION_OF_CELL_SURFACE_RECEPTORS_BY_RECRUITING_THEM_TO_CLATHRIN_ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
| 0.3 | 0.6 | REACTOME_HS_GAG_DEGRADATION | Genes involved in HS-GAG degradation |
| 0.3 | 2.4 | REACTOME_CYCLIN_A_B1_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 0.3 | 4.1 | REACTOME_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.3 | 4.7 | REACTOME_UNWINDING_OF_DNA | Genes involved in Unwinding of DNA |
| 0.3 | 2.5 | REACTOME_ASSOCIATION_OF_LICENSING_FACTORS_WITH_THE_PRE_REPLICATIVE_COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
| 0.3 | 2.7 | REACTOME_HYALURONAN_UPTAKE_AND_DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
| 0.3 | 7.7 | REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_2_PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
| 0.2 | 10.1 | REACTOME_G1_PHASE | Genes involved in G1 Phase |
| 0.2 | 3.9 | REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.2 | 7.4 | REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
| 0.2 | 4.2 | REACTOME_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
| 0.2 | 1.3 | REACTOME_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.2 | 1.5 | REACTOME_COMPLEMENT_CASCADE | Genes involved in Complement cascade |
| 0.2 | 4.1 | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
| 0.2 | 2.3 | REACTOME_SLBP_DEPENDENT_PROCESSING_OF_REPLICATION_DEPENDENT_HISTONE_PRE_MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
| 0.2 | 5.0 | REACTOME_GLUTATHIONE_CONJUGATION | Genes involved in Glutathione conjugation |
| 0.2 | 1.7 | REACTOME_RORA_ACTIVATES_CIRCADIAN_EXPRESSION | Genes involved in RORA Activates Circadian Expression |
| 0.2 | 10.1 | REACTOME_AMYLOIDS | Genes involved in Amyloids |
| 0.2 | 3.6 | REACTOME_EARLY_PHASE_OF_HIV_LIFE_CYCLE | Genes involved in Early Phase of HIV Life Cycle |
| 0.2 | 0.9 | REACTOME_PLATELET_SENSITIZATION_BY_LDL | Genes involved in Platelet sensitization by LDL |
| 0.2 | 9.4 | REACTOME_FORMATION_OF_THE_TERNARY_COMPLEX_AND_SUBSEQUENTLY_THE_43S_COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 0.2 | 2.1 | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
| 0.2 | 2.3 | REACTOME_FANCONI_ANEMIA_PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.2 | 6.1 | REACTOME_GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
| 0.2 | 1.3 | REACTOME_KERATAN_SULFATE_DEGRADATION | Genes involved in Keratan sulfate degradation |
| 0.2 | 0.7 | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.2 | 1.0 | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.2 | 1.0 | REACTOME_THE_NLRP3_INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
| 0.2 | 3.6 | REACTOME_HORMONE_SENSITIVE_LIPASE_HSL_MEDIATED_TRIACYLGLYCEROL_HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.2 | 14.7 | REACTOME_MITOTIC_PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.2 | 3.1 | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.2 | 1.5 | REACTOME_HEMOSTASIS | Genes involved in Hemostasis |
| 0.1 | 2.9 | REACTOME_DESTABILIZATION_OF_MRNA_BY_BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
| 0.1 | 0.6 | REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_ | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
| 0.1 | 0.7 | REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.1 | 1.6 | REACTOME_BASE_FREE_SUGAR_PHOSPHATE_REMOVAL_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
| 0.1 | 2.5 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.1 | 1.4 | REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
| 0.1 | 1.9 | REACTOME_ACTIVATION_OF_GENES_BY_ATF4 | Genes involved in Activation of Genes by ATF4 |
| 0.1 | 12.0 | REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
| 0.1 | 2.2 | REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.1 | 1.6 | REACTOME_POL_SWITCHING | Genes involved in Polymerase switching |
| 0.1 | 0.6 | REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
| 0.1 | 0.7 | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
| 0.1 | 4.6 | REACTOME_MYOGENESIS | Genes involved in Myogenesis |
| 0.1 | 1.1 | REACTOME_GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.1 | 1.1 | REACTOME_DSCAM_INTERACTIONS | Genes involved in DSCAM interactions |
| 0.1 | 1.2 | REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
| 0.1 | 1.4 | REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
| 0.1 | 0.9 | REACTOME_P2Y_RECEPTORS | Genes involved in P2Y receptors |
| 0.1 | 3.7 | REACTOME_GLYCOSPHINGOLIPID_METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.1 | 1.9 | REACTOME_GLUCOSE_METABOLISM | Genes involved in Glucose metabolism |
| 0.1 | 8.2 | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | Genes involved in Peptide ligand-binding receptors |
| 0.1 | 1.4 | REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.1 | 0.7 | REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.1 | 1.5 | REACTOME_ALPHA_LINOLENIC_ACID_ALA_METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.1 | 2.4 | REACTOME_NUCLEAR_SIGNALING_BY_ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
| 0.1 | 5.8 | REACTOME_COLLAGEN_FORMATION | Genes involved in Collagen formation |
| 0.1 | 5.4 | REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 0.1 | 0.9 | REACTOME_CS_DS_DEGRADATION | Genes involved in CS/DS degradation |
| 0.1 | 1.7 | REACTOME_SULFUR_AMINO_ACID_METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.1 | 4.2 | REACTOME_MUSCLE_CONTRACTION | Genes involved in Muscle contraction |
| 0.1 | 5.9 | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.1 | 1.1 | REACTOME_3_UTR_MEDIATED_TRANSLATIONAL_REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
| 0.1 | 0.7 | REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 0.1 | 1.1 | REACTOME_STEROID_HORMONES | Genes involved in Steroid hormones |
| 0.1 | 6.0 | REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_ | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 0.1 | 2.3 | REACTOME_SIGNALING_BY_HIPPO | Genes involved in Signaling by Hippo |
| 0.1 | 2.3 | REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 0.1 | 0.1 | REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
| 0.1 | 0.7 | REACTOME_METABOLISM_OF_POLYAMINES | Genes involved in Metabolism of polyamines |
| 0.1 | 3.0 | REACTOME_HS_GAG_BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.1 | 1.1 | REACTOME_SIGNAL_TRANSDUCTION_BY_L1 | Genes involved in Signal transduction by L1 |
| 0.1 | 1.0 | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.1 | 0.4 | REACTOME_INTRINSIC_PATHWAY | Genes involved in Intrinsic Pathway |
| 0.1 | 7.0 | REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
| 0.1 | 1.3 | REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN | Genes involved in Signalling to p38 via RIT and RIN |
| 0.1 | 0.7 | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 0.1 | 0.6 | REACTOME_CTNNB1_PHOSPHORYLATION_CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.1 | 0.8 | REACTOME_SYNTHESIS_OF_PE | Genes involved in Synthesis of PE |
| 0.1 | 1.7 | REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
| 0.1 | 0.2 | REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 0.1 | 3.1 | REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
| 0.1 | 2.0 | REACTOME_TIGHT_JUNCTION_INTERACTIONS | Genes involved in Tight junction interactions |
| 0.1 | 0.8 | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.1 | 2.7 | REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.1 | 4.6 | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.1 | 0.7 | REACTOME_ELONGATION_ARREST_AND_RECOVERY | Genes involved in Elongation arrest and recovery |
| 0.1 | 1.1 | REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES | Genes involved in Generation of second messenger molecules |
| 0.1 | 0.2 | REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
| 0.1 | 0.3 | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 0.1 | 0.5 | REACTOME_ENOS_ACTIVATION_AND_REGULATION | Genes involved in eNOS activation and regulation |
| 0.1 | 0.7 | REACTOME_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.1 | 0.3 | REACTOME_PACKAGING_OF_TELOMERE_ENDS | Genes involved in Packaging Of Telomere Ends |
| 0.1 | 0.4 | REACTOME_P38MAPK_EVENTS | Genes involved in p38MAPK events |
| 0.1 | 1.1 | REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 0.1 | 1.6 | REACTOME_DNA_REPAIR | Genes involved in DNA Repair |
| 0.0 | 1.0 | REACTOME_MEIOTIC_RECOMBINATION | Genes involved in Meiotic Recombination |
| 0.0 | 0.6 | REACTOME_GAP_JUNCTION_ASSEMBLY | Genes involved in Gap junction assembly |
| 0.0 | 0.1 | REACTOME_SEROTONIN_RECEPTORS | Genes involved in Serotonin receptors |
| 0.0 | 0.5 | REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 0.0 | 1.0 | REACTOME_METABOLISM_OF_PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.0 | 0.2 | REACTOME_PECAM1_INTERACTIONS | Genes involved in PECAM1 interactions |
| 0.0 | 1.0 | REACTOME_MRNA_SPLICING_MINOR_PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
| 0.0 | 2.6 | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | Genes involved in Cell surface interactions at the vascular wall |
| 0.0 | 1.8 | REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.0 | 0.5 | REACTOME_OXYGEN_DEPENDENT_PROLINE_HYDROXYLATION_OF_HYPOXIA_INDUCIBLE_FACTOR_ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 0.0 | 0.9 | REACTOME_KINESINS | Genes involved in Kinesins |
| 0.0 | 1.3 | REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
| 0.0 | 0.9 | REACTOME_PYRIMIDINE_METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.0 | 0.9 | REACTOME_TRANSLATION | Genes involved in Translation |
| 0.0 | 0.3 | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
| 0.0 | 0.3 | REACTOME_ROLE_OF_DCC_IN_REGULATING_APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.0 | 0.4 | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.0 | 0.5 | REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.0 | 0.2 | REACTOME_ER_PHAGOSOME_PATHWAY | Genes involved in ER-Phagosome pathway |
| 0.0 | 0.5 | REACTOME_INHIBITION_OF_VOLTAGE_GATED_CA2_CHANNELS_VIA_GBETA_GAMMA_SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
| 0.0 | 0.3 | REACTOME_REGULATION_OF_PYRUVATE_DEHYDROGENASE_PDH_COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 0.0 | 0.4 | REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING | Genes involved in Growth hormone receptor signaling |
| 0.0 | 0.9 | REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS | Genes involved in Host Interactions of HIV factors |
| 0.0 | 0.1 | REACTOME_PLATELET_HOMEOSTASIS | Genes involved in Platelet homeostasis |
| 0.0 | 1.0 | REACTOME_RECYCLING_PATHWAY_OF_L1 | Genes involved in Recycling pathway of L1 |
| 0.0 | 0.3 | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.0 | 3.4 | REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 0.0 | 0.3 | REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_RAS | Genes involved in CREB phosphorylation through the activation of Ras |
| 0.0 | 0.1 | REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 0.0 | 0.7 | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.0 | 0.3 | REACTOME_RNA_POL_I_TRANSCRIPTION_INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
| 0.0 | 0.1 | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.0 | 0.3 | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
| 0.0 | 0.2 | REACTOME_SYNTHESIS_OF_PC | Genes involved in Synthesis of PC |
| 0.0 | 0.3 | REACTOME_TRNA_AMINOACYLATION | Genes involved in tRNA Aminoacylation |
